Boeing R&D decreased by 6.3% to $903.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $844.00M to $903.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 12.6% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $497.00M | $575.00M | $678.00M | $633.00M | $698.00M | $727.00M | $794.00M | $741.00M | $797.00M | $958.00M | $881.00M | $868.00M | $954.00M | $1.15B | $836.00M | $844.00M | $910.00M | $897.00M | $964.00M | $903.00M |
| QoQ Change | — | +15.7% | +17.9% | -6.6% | +10.3% | +4.2% | +9.2% | -6.7% | +7.6% | +20.2% | -8.0% | -1.5% | +9.9% | +21.0% | -27.6% | +1.0% | +7.8% | -1.4% | +7.5% | -6.3% |
| YoY Change | — | — | — | — | +40.4% | +26.4% | +17.1% | +17.1% | +14.2% | +31.8% | +11.0% | +17.1% | +19.7% | +20.5% | -5.1% | -2.8% | -4.6% | -22.3% | +15.3% | +7.0% |
| Segment | Q1 '26 |
|---|---|
| Commercial Airplanes | $603.00M |
| Defense, Space & Security | $174.00M |
| Global Services | $22.00M |
| Total | $903.00M |